(PharmaNewsWire.Com, June 09, 2017 ) “Middle-East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market” research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 6.69% to reach USD 275.84 million by 2020, from USD 199.54 million in 2015. Acute Ischemic stroke can be defined as failing of function in certain parts of brain due to lack of blood supply to the brain. With diabetes, the probability of stroke rises and strokes can cause long term disorders. The most found after of acute ischemic strokes is due the formation of atherosclerosis plaques that block or narrow blood vessels. There are some symptoms like inability to move, problem in speaking, etc. For full report refer to “http://www.marketdataforecast.com/market-reports/middle-east-and-africa-acute-ischemic-stroke-diagnosis-market-270/ “
Key factors which affect and thereby cause changes to the market dynamics are studied essentially and are presented in a well-known way in the report. Some of those factors are • Increasing prevalence of acute ischemia stroke cases, progress in surgical procedures along with growing geriatric population, rising demand for minimally invasive surgical procedures • Due to high cost of those surgical procedures, lack of transparent reimbursement policies, and scarcity of expertise
For granular level understanding the Acute Ischemic Stroke Diagnosis and Treatment Market is segmented based on Diagnostic Type and Surgery Type, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Diagnostic Type: Computed Tomography Magnetic Resonance Imaging Ultrasound Cerebral angiography Nuclear Imaging Based on Surgery Type: Carotid Endarterectomy Angioplasty Endovascular Mechanical Thrombectomy
On the Basis of geography Africa & Middle-East Acute Ischemic Stroke Diagnosis and Treatment Market is analyzed under Middle-East and Africa. Middle-East is the largest market within this region having high share market due to high disposable income. Africa is the expected to be the fastest growing region due to increasing prevalence of various cardiovascular diseases such as Ischemic stroke and high population base. Some of the key players that operate in the Middle-East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market include Abbott Laboratories, Philips Healthcare, Covidien plc, Penumbra, Inc., Johnson & Johnson, Siemens Healthcare, GE Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd. New Product launches and cooperation are some of the key strategies adopted by leading industry players. In March, 2015, FDA approved WATCHMAN, a left atrial appendage closure device prepared to prevent stroke in patients with atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, through a minimally invasive technique prepared to access the common carotid artery. Buy now “http://www.marketdataforecast.com/market-reports/middle-east-and-africa-acute-ischemic-stroke-diagnosis-market-270/” The Middle-East and Africa Acute Ischemic Stroke Diagnosis and Treatment Market report offers wide-range of scope: • Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole • Know more about key areas of industry growth via detailed Segment-level analysis on basis of Diagnostic Type and Surgery Type along with market size forecasts and y-o-y estimations • Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics • Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics • Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is one of the prominent market research companies which offers syndicated as well as customized research services to individual or corporate clients. Their syndicated research reports contain Market Sizing and forecasts for 5-year period with a niche level of segmentation providing you with more focused insights whereas the consult research services can fetch the distinctive data requirements at competitive industry costs. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
